154 related articles for article (PubMed ID: 22402209)
21. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.
Huang R; Zheng J; Li S; Tao T; Ma J; Liu W
Acta Obstet Gynecol Scand; 2015 May; 94(5):494-500. PubMed ID: 25711494
[TBL] [Abstract][Full Text] [Related]
24. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
[TBL] [Abstract][Full Text] [Related]
25. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S; Abbott JA; Smith CA; Bensoussan A
BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
[TBL] [Abstract][Full Text] [Related]
26. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
27. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
28. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
29. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
30. Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations.
Butler AE; Abouseif A; Dargham SR; Sathyapalan T; Atkin SL
Sci Rep; 2020 Nov; 10(1):18895. PubMed ID: 33144665
[TBL] [Abstract][Full Text] [Related]
31. Ethnic differences in the phenotypic expression of polycystic ovary syndrome.
Zhao Y; Qiao J
Steroids; 2013 Aug; 78(8):755-60. PubMed ID: 23624030
[TBL] [Abstract][Full Text] [Related]
32. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
[TBL] [Abstract][Full Text] [Related]
33. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
Popovska-Dimova Z; Krstevska B
Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
[TBL] [Abstract][Full Text] [Related]
34. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years.
Bili H; Laven J; Imani B; Eijkemans MJ; Fauser BC
Eur J Endocrinol; 2001 Dec; 145(6):749-55. PubMed ID: 11720900
[TBL] [Abstract][Full Text] [Related]
35. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
36. Screening for a Simple and Effective Indicator of Insulin Resistance in Chinese Reproductive-Aged Women, with the Insulin Clamp Technique as a Reference.
Long J; Li L; Wang F; Yang G; Cheng W; Wei J; Chen M; Liu D
Metab Syndr Relat Disord; 2019 Oct; 17(8):423-429. PubMed ID: 31305214
[No Abstract] [Full Text] [Related]
37. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
38. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
39. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women.
Dou P; Ju H; Shang J; Li X; Xue Q; Xu Y; Guo X
J Ovarian Res; 2016 Aug; 9(1):51. PubMed ID: 27557677
[TBL] [Abstract][Full Text] [Related]
40. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
